Exchange Announcement • 10 Dec 2024 20:15
Exchange Announcement • 25 Nov 2024 20:09
Exchange Announcement • 13 Nov 2024 05:45
Exchange Announcement • 12 Nov 2024 08:00
Exchange Announcement • 05 Nov 2024 05:31
ENTITY
IN8bio (INAB US)
IN8bio (INAB US)
6
Analysis
Health Care • United States
IN8bio, Inc. operates as a clinical-stage biotechnology company. The Company focuses on developing therapies for the treatment of cancers, including solid tumors, by employing allogeneic, autologous, and genetically modified gamma-delta T cells. IN8bio serves customers in the United States.
more
x